Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-03-000736
Filing Date
2003-09-24
Accepted
2003-09-24 11:51:04
Documents
2
Period of Report
2003-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o10822e6vk.htm 6-K 15965
3 GRAPHIC o10822o1082201.gif GRAPHIC 3108
  Complete submission text file 0001130319-03-000736.txt   20579
Mailing Address
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 03907327
SIC: 2834 Pharmaceutical Preparations